GPT Healthcare (NSE:GPTHEALTH) Ending Cash Position: ₹0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:GPTHEALTH GPT Healthcare Ltd NSE:GPTHEALTH
44 GF Score
Price ₹160.70
! 3 Warning Signs
View Full Analysis

What is GPT Healthcare Ending Cash Position?

GPT Healthcare NSE:GPTHEALTH -0.42% 44 Ending Cash Position is ₹0 Mil as of Jun. 2026. GuruFocus rates NSE:GPTHEALTH with a GF Score™ of 44/100. The stock has 3 warning signs investors should review.

GPT Healthcare's Ending Cash Position for the quarter that ended in Jun. 2026 was ₹0 Mil.

GPT Healthcare's annual Ending Cash Position declined from Mar. 2024 (₹17 Mil) to Mar. 2025 (₹17 Mil) but then increased from Mar. 2025 (₹17 Mil) to Mar. 2026 (₹41 Mil).

GPT Healthcare Ending Cash Position Related Terms

GPT Healthcare Ending Cash Position Historical Data

* Premium members only.

The historical data trend for GPT Healthcare's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GPT Healthcare Ending Cash Position Chart

GPT Healthcare Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Ending Cash Position
Get a 7-Day Free Trial 82.68 65.99 16.93 16.59 41.33

GPT Healthcare Quarterly Data
Mar21 Mar22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
NSE:GPTHEALTH
44GF Score
GPT Healthcare Ltd NSE:GPTHEALTH
Ending Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

GPT Healthcare Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

GPT Healthcare's Ending Cash Position for the fiscal year that ended in Mar. 2026 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=16.588+24.744
=41

GPT Healthcare's Ending Cash Position for the quarter that ended in Jun. 2026 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=0+0
=0

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of ₹0 Mil mean?
GPT Healthcare (NSE:GPTHEALTH) has a Ending Cash Position of ₹0 Mil as of Jun. 2026. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on GPT Healthcare and its competitors.
Is GPT Healthcare's Ending Cash Position too high?
GPT Healthcare's current Ending Cash Position is ₹0 Mil. Overall, GPT Healthcare has a GF Score™ of 44/100, reflecting its overall financial health beyond just this single metric.
How does GPT Healthcare's Ending Cash Position compare to HCA and THC?
GPT Healthcare's Ending Cash Position of ₹0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Healthcare Providers & Services company?
A good Ending Cash Position depends on the Healthcare Providers & Services industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on GPT Healthcare and its competitors. GPT Healthcare's current Ending Cash Position is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GPT Healthcare stock overvalued right now?
GPT Healthcare (NSE:GPTHEALTH) has a current Ending Cash Position of ₹0 Mil. The current Ending Cash Position is ₹0 Mil. GPT Healthcare's overall GF Score™ is 44/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For GPT Healthcare (NSE:GPTHEALTH), the current Ending Cash Position is ₹0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

GPT Healthcare Business Description

Other Exchanges 544131:India
Address Sector III, GPT Centre, JC-25, Salt Lake, Kolkata, WB, IND, 700106
GPT Healthcare Ltd is engaged in the healthcare sector. It operates a chain of mid-sized full-service hospitals under the ILS brand. It provides integrated healthcare services, with a focus on secondary and tertiary care and operates four multispecialty hospitals in Dum Dum, Salt Lake and Howrah in West Bengal and Agartala in Tripura with a total capacity of approximately 561 beds. It offers a comprehensive range of healthcare services across over 35 specialities and super specialities, including internal medicine and diabetology, nephrology (including renal transplants), laparoscopic and general surgery, gynaecology and obstetrics, critical care, gastroenterology, orthopaedics and joint replacements, interventional cardiology, neurology, neurosurgery, paediatrics, and neonatology.
44GF Score

Get the complete analysis for NSE:GPTHEALTH

Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹160.70
Price